Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain. 22 Nov Dr D Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain